{"id":6891,"date":"2023-05-31T01:12:03","date_gmt":"2023-05-31T01:12:03","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6891"},"modified":"2023-08-29T17:58:05","modified_gmt":"2023-08-29T17:58:05","slug":"neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6891","title":{"rendered":"Neurotech\u83b7\u51c6\u5ef6\u957fNTI164\u5bf9\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\u60a3\u8005\u7684\u8bd5\u9a8c\u5242\u91cf"},"content":{"rendered":"<p>Human Research Ethics Committee\uff08HREC\uff09\u5df2\u6279\u51c6Neurotech International\uff08ASX: NTI\uff09\u5c06\u4e3b\u5bfc\u836f\u7269NTI164\u7528\u4e8e\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\uff08ASD\uff09\u60a3\u8005\u7684\u5242\u91cf\u5ef6\u957f\u4e24\u5e74\uff0c\u8fd9\u4e9b\u60a3\u8005\u4e4b\u524d\u53c2\u52a0\u4e86\u8be5\u516c\u53f8\u7684I\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>\u8fd9\u6b21\u5ef6\u671f\u5c06\u4f7f11\u540d\u5728\u6700\u521d\u768418\u4e2a\u6708\u8bd5\u9a8c\u671f\u540e\u7ee7\u7eed\u6bcf\u5929\u53e3\u670d\u8be5\u5927\u9ebb\u7d20\u836f\u7269\u7684\u60a3\u8005\u7ee7\u7eed\u63a5\u53d7\u6cbb\u7597\u4e24\u5e74\u3002<\/p>\n<p>\u4ed6\u4eec\u5c06\u5728\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u901a\u8fc7\u58a8\u5c14\u672c\u7684Monash Medical Centre\u8fc7\u6e21\u5230\u4e00\u4e2a\u540c\u60c5\u6027\u4f7f\u7528\u8ba1\u5212\uff0c\u795e\u7ecf\u6280\u672f\u516c\u53f8\u5c06\u7ee7\u7eed\u6309\u7167HREC\u7684\u8981\u6c42\u5b9a\u671f\u6536\u96c6\u5b89\u5168\u4fe1\u606f\u3002<\/p>\n<p>\u8fd9\u4e00\u8fc7\u6e21\u5c06\u5728\u7279\u522b\u51c6\u5165\u8ba1\u5212B\u7c7b\uff08Special Access Scheme Category B\uff09\u9014\u5f84\u4e0b\u8fdb\u884c\uff0c\u8be5\u9014\u5f84\u5141\u8bb8\u6ce8\u518c\u7684\u533b\u7597\u5de5\u4f5c\u8005\u4e3a\u5176\u75c5\u4eba\u5f00\u5177\u672a\u7ecf\u6279\u51c6\u7684\u836f\u7269\u3002<\/p>\n<p>\u8fd9\u610f\u5473\u7740Neurotech\u516c\u53f8\u5c06\u4eceMonash\u83b7\u5f97\u4e0e\u836f\u623f\u3001\u4e34\u5e8a\u533b\u751f\u548c\u75c5\u7406\u8d39\u7528\u6709\u5173\u7684\u67d0\u4e9b\u8d39\u7528\u7684\u51cf\u514d\uff0c\u8fd9\u5c06\u4f7f\u6bcf\u6708\u836f\u54c1\u4f9b\u5e94\u7684\u603b\u4f53\u6210\u672c\u5927\u5927\u964d\u4f4e\u3002<\/p>\n<h2>\u5242\u91cf\u6269\u5c55<\/h2>\n<p>Neurotech\u6267\u884c\u8463\u4e8bThomas Duthy\u535a\u58eb\u8bf4\uff0c\u5242\u91cf\u5ef6\u957f\u662f\u7531\u4e34\u5e8a\u8bd5\u9a8c\u60a3\u8005\u53d1\u8d77\u7684\u3002<\/p>\n<p>\u4ed6\u8bf4\uff1a&#8221;\u6211\u4eec\u7684ASD\u7814\u7a76\u663e\u793a\uff0c\u6211\u4eec\u7684NTI164\u53e3\u670d\u5236\u5242\u5177\u6709\u51fa\u8272\u7684\u4e34\u5e8a\u7597\u6548\u548c\u5b89\u5168\u6027\u3002&#8221;<\/p>\n<p>&#8220;\u9274\u4e8e\u4ed6\u4eec\u7684\u4e34\u5e8a\u75c7\u72b6\u5f97\u5230\u4e86\u660e\u663e\u7684\u6539\u5584\uff0c\u800c\u4e14\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\uff0c\u6211\u4eec\u7684\u6cbb\u7597\u5177\u6709\u51fa\u8272\u7684\u5b89\u5168\u6027\uff0c\u6240\u670911\u540d\u60a3\u8005\u90fd\u8981\u6c42\u5728\u53ef\u9884\u89c1\u7684\u672a\u6765\u7ee7\u7eed\u6cbb\u7597\u3002&#8221;<\/p>\n<h2>\u79ef\u6781\u7684\u7ed3\u679c<\/h2>\n<p>3\u6708\uff0cNeurotech\u62a5\u544a\u4e86NTI164\u5bf9\u81ea\u95ed\u75c7\u513f\u7ae5\u7684<a href=\"http:\/\/smallcaps-production.test\/neurotech-clinical-trial-lead-drug-candidate-autism-spectrum-disorder-results\/?lang=cn\">\u9996\u6b21\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u7684\u79ef\u6781\u7ed3\u679c<\/a>\u3002<\/p>\n<p>\u7ed3\u679c\u663e\u793a\uff0c\u572852\u5468\u65f6\uff0c\u5728\u5927\u91cf\u4e34\u5e8a\u9a8c\u8bc1\u7684\u8bc4\u4f30\u4e2d\u90fd\u6709 &#8220;\u660e\u663e\u7684\u76ca\u5904&#8221;\u3002<\/p>\n<p>\u9996\u5e2d\u8c03\u67e5\u5458Michael Fahey\u6559\u6388\u8bf4\uff0c\u60a3\u8005\u5728\u75be\u75c5\u7684\u4e25\u91cd\u7a0b\u5ea6\u3001\u793e\u4f1a\u5316\u548c\u9002\u5e94\u6027\u884c\u4e3a\u65b9\u9762\u8868\u73b0\u51fa &#8220;\u5168\u9762\u6539\u5584&#8221;\u3002<\/p>\n<p>\u8fd9\u4e9b\u597d\u5904\u4e0e\u7f3a\u4e4f\u4e25\u91cd\u7684\u4e0d\u826f\u4e8b\u4ef6\u548c &#8220;\u5e72\u51c0\u7684 &#8220;\u75c5\u7406\u7ed3\u679c\u76f8\u914d\u5408\u3002<\/p>\n<h2>\u65e9\u4e9b\u65f6\u5019\u7684\u5ef6\u671f<\/h2>\n<p>\u4eca\u5929\u7684\u6d88\u606f\u662f\u7ee7<a href=\"http:\/\/smallcaps-production.test\/neurotech-international-approval-extend-nti164-clinical-trial-treatment-pandas-pans\/?lang=cn\">\u65e9\u524dHREC\u5ef6\u957fNTI164<\/a>\u6cbb\u7597\u4e0e\u94fe\u7403\u83cc\u611f\u67d3\u76f8\u5173\u7684\u5c0f\u513f\u81ea\u8eab\u514d\u75ab\u6027\u795e\u7ecf\u7cbe\u795e\u969c\u788d\uff08PANDAS\uff09\u548c\u5c0f\u513f\u6025\u6027\u53d1\u4f5c\u795e\u7ecf\u7cbe\u795e\u7efc\u5408\u5f81\uff08PANS\uff09\u7684\u671f\u9650\u4e4b\u540e\u3002<\/p>\n<p>\u8be5\u6279\u51c6\u5c06\u5141\u8bb8\u76ee\u524dI\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53c2\u4e0e\u8005\u7ee7\u7eed\u63a5\u53d7\u6cbb\u7597\uff0c\u76f4\u81f320\u5c81\u3002<\/p>\n<p>Neurotech\u672c\u6708\u65e9\u4e9b\u65f6\u5019\u5b8c\u6210\u4e8615\u540d\u513f\u7ae5\u60a3\u8005\u7684\u62db\u52df\uff0c\u9884\u8ba1\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u4f1a\u6709\u4e34\u5e8a\u7ed3\u679c\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Human Research Ethics Committee\uff08HREC\uff09\u5df2\u6279\u51c6Neurotech International\uff08ASX: NTI\uff09\u5c06\u4e3b\u5bfc\u836f\u7269NTI164\u7528\u4e8e\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\uff08ASD\uff09\u60a3\u8005\u7684\u5242\u91cf\u5ef6\u957f\u4e24\u5e74\uff0c\u8fd9\u4e9b\u60a3\u8005\u4e4b\u524d\u53c2\u52a0\u4e86\u8be5\u516c\u53f8\u7684I\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u8fd9\u6b21\u5ef6\u671f\u5c06\u4f7f11\u540d\u5728\u6700\u521d\u768418\u4e2a\u6708\u8bd5\u9a8c\u671f\u540e\u7ee7\u7eed\u6bcf\u5929\u53e3\u670d\u8be5\u5927\u9ebb\u7d20\u836f\u7269\u7684\u60a3\u8005\u7ee7\u7eed\u63a5\u53d7\u6cbb\u7597\u4e24\u5e74\u3002 \u4ed6\u4eec\u5c06\u5728\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u901a\u8fc7\u58a8\u5c14\u672c\u7684Monash Medical Centre\u8fc7\u6e21\u5230\u4e00\u4e2a\u540c\u60c5\u6027\u4f7f\u7528\u8ba1\u5212\uff0c\u795e\u7ecf\u6280\u672f\u516c\u53f8\u5c06\u7ee7\u7eed\u6309\u7167HREC\u7684\u8981\u6c42\u5b9a\u671f\u6536\u96c6\u5b89\u5168\u4fe1\u606f\u3002 \u8fd9\u4e00\u8fc7\u6e21\u5c06\u5728\u7279\u522b\u51c6\u5165\u8ba1\u5212B\u7c7b\uff08Special Access Scheme Category B\uff09\u9014\u5f84\u4e0b\u8fdb\u884c\uff0c\u8be5\u9014\u5f84\u5141\u8bb8\u6ce8\u518c\u7684\u533b\u7597\u5de5\u4f5c\u8005\u4e3a\u5176\u75c5\u4eba\u5f00\u5177\u672a\u7ecf\u6279\u51c6\u7684\u836f\u7269\u3002 \u8fd9\u610f\u5473\u7740Neurotech\u516c\u53f8\u5c06\u4eceMonash\u83b7\u5f97\u4e0e\u836f\u623f\u3001\u4e34\u5e8a\u533b\u751f\u548c\u75c5\u7406\u8d39\u7528\u6709\u5173\u7684\u67d0\u4e9b\u8d39\u7528\u7684\u51cf\u514d\uff0c\u8fd9\u5c06\u4f7f\u6bcf\u6708\u836f\u54c1\u4f9b\u5e94\u7684\u603b\u4f53\u6210\u672c\u5927\u5927\u964d\u4f4e\u3002 \u5242\u91cf\u6269\u5c55 Neurotech\u6267\u884c\u8463\u4e8bThomas Duthy\u535a\u58eb\u8bf4\uff0c\u5242\u91cf\u5ef6\u957f\u662f\u7531\u4e34\u5e8a\u8bd5\u9a8c\u60a3\u8005\u53d1\u8d77\u7684\u3002 \u4ed6\u8bf4\uff1a&#8221;\u6211\u4eec\u7684ASD\u7814\u7a76\u663e\u793a\uff0c\u6211\u4eec\u7684NTI164\u53e3\u670d\u5236\u5242\u5177\u6709\u51fa\u8272\u7684\u4e34\u5e8a\u7597\u6548\u548c\u5b89\u5168\u6027\u3002&#8221; &#8220;\u9274\u4e8e\u4ed6\u4eec\u7684\u4e34\u5e8a\u75c7\u72b6\u5f97\u5230\u4e86\u660e\u663e\u7684\u6539\u5584\uff0c\u800c\u4e14\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\uff0c\u6211\u4eec\u7684\u6cbb\u7597\u5177\u6709\u51fa\u8272\u7684\u5b89\u5168\u6027\uff0c\u6240\u670911\u540d\u60a3\u8005\u90fd\u8981\u6c42\u5728\u53ef\u9884\u89c1\u7684\u672a\u6765\u7ee7\u7eed\u6cbb\u7597\u3002&#8221; \u79ef\u6781\u7684\u7ed3\u679c 3\u6708\uff0cNeurotech\u62a5\u544a\u4e86NTI164\u5bf9\u81ea\u95ed\u75c7\u513f\u7ae5\u7684\u9996\u6b21\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u7684\u79ef\u6781\u7ed3\u679c\u3002 \u7ed3\u679c\u663e\u793a\uff0c\u572852\u5468\u65f6\uff0c\u5728\u5927\u91cf\u4e34\u5e8a\u9a8c\u8bc1\u7684\u8bc4\u4f30\u4e2d\u90fd\u6709 &#8220;\u660e\u663e\u7684\u76ca\u5904&#8221;\u3002 \u9996\u5e2d\u8c03\u67e5\u5458Michael Fahey\u6559\u6388\u8bf4\uff0c\u60a3\u8005\u5728\u75be\u75c5\u7684\u4e25\u91cd\u7a0b\u5ea6\u3001\u793e\u4f1a\u5316\u548c\u9002\u5e94\u6027\u884c\u4e3a\u65b9\u9762\u8868\u73b0\u51fa &#8220;\u5168\u9762\u6539\u5584&#8221;\u3002 \u8fd9\u4e9b\u597d\u5904\u4e0e\u7f3a\u4e4f\u4e25\u91cd\u7684\u4e0d\u826f\u4e8b\u4ef6\u548c &#8220;\u5e72\u51c0\u7684 &#8220;\u75c5\u7406\u7ed3\u679c\u76f8\u914d\u5408\u3002 \u65e9\u4e9b\u65f6\u5019\u7684\u5ef6\u671f \u4eca\u5929\u7684\u6d88\u606f\u662f\u7ee7\u65e9\u524dHREC\u5ef6\u957fNTI164\u6cbb\u7597\u4e0e\u94fe\u7403\u83cc\u611f\u67d3\u76f8\u5173\u7684\u5c0f\u513f\u81ea\u8eab\u514d\u75ab\u6027\u795e\u7ecf\u7cbe\u795e\u969c\u788d\uff08PANDAS\uff09\u548c\u5c0f\u513f\u6025\u6027\u53d1\u4f5c\u795e\u7ecf\u7cbe\u795e\u7efc\u5408\u5f81\uff08PANS\uff09\u7684\u671f\u9650\u4e4b\u540e\u3002 \u8be5\u6279\u51c6\u5c06\u5141\u8bb8\u76ee\u524dI\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53c2\u4e0e\u8005\u7ee7\u7eed\u63a5\u53d7\u6cbb\u7597\uff0c\u76f4\u81f320\u5c81\u3002 Neurotech\u672c\u6708\u65e9\u4e9b\u65f6\u5019\u5b8c\u6210\u4e8615\u540d\u513f\u7ae5\u60a3\u8005\u7684\u62db\u52df\uff0c\u9884\u8ba1\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u4f1a\u6709\u4e34\u5e8a\u7ed3\u679c\u3002<\/p>\n","protected":false},"author":4,"featured_media":19167,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[408],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Neurotech\u83b7\u51c6\u5ef6\u957fNTI164\u5bf9\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\u60a3\u8005\u7684\u8bd5\u9a8c\u5242\u91cf<\/title>\n<meta name=\"description\" content=\"Human Research Ethics Committee\uff08HREC\uff09\u5df2\u6279\u51c6Neurotech International\uff08ASX: NTI\uff09\u5c06\u4e3b\u5bfc\u836f\u7269NTI164\u7528\u4e8e\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\uff08ASD\uff09\u60a3\u8005\u7684\u5242\u91cf\u5ef6\u957f\u4e24\u5e74\uff0c\u8fd9\u4e9b\u60a3\u8005\u4e4b\u524d\u53c2\u52a0\u4e86\u8be5\u516c\u53f8\u7684I\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurotech\u83b7\u51c6\u5ef6\u957fNTI164\u5bf9\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\u60a3\u8005\u7684\u8bd5\u9a8c\u5242\u91cf\" \/>\n<meta property=\"og:description\" content=\"Human Research Ethics Committee\uff08HREC\uff09\u5df2\u6279\u51c6Neurotech International\uff08ASX: NTI\uff09\u5c06\u4e3b\u5bfc\u836f\u7269NTI164\u7528\u4e8e\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\uff08ASD\uff09\u60a3\u8005\u7684\u5242\u91cf\u5ef6\u957f\u4e24\u5e74\uff0c\u8fd9\u4e9b\u60a3\u8005\u4e4b\u524d\u53c2\u52a0\u4e86\u8be5\u516c\u53f8\u7684I\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-31T01:12:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:58:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Neurotech-International-ASX-NTI-dosage-extension-NTI164-patients-in-autism-spectrum-disorder-trial-compassionate-use.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/\",\"name\":\"Neurotech\u83b7\u51c6\u5ef6\u957fNTI164\u5bf9\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\u60a3\u8005\u7684\u8bd5\u9a8c\u5242\u91cf\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-05-31T01:12:03+00:00\",\"dateModified\":\"2023-08-29T17:58:05+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"Human Research Ethics Committee\uff08HREC\uff09\u5df2\u6279\u51c6Neurotech International\uff08ASX: NTI\uff09\u5c06\u4e3b\u5bfc\u836f\u7269NTI164\u7528\u4e8e\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\uff08ASD\uff09\u60a3\u8005\u7684\u5242\u91cf\u5ef6\u957f\u4e24\u5e74\uff0c\u8fd9\u4e9b\u60a3\u8005\u4e4b\u524d\u53c2\u52a0\u4e86\u8be5\u516c\u53f8\u7684I\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurotech\u83b7\u51c6\u5ef6\u957fNTI164\u5bf9\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\u60a3\u8005\u7684\u8bd5\u9a8c\u5242\u91cf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Neurotech\u83b7\u51c6\u5ef6\u957fNTI164\u5bf9\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\u60a3\u8005\u7684\u8bd5\u9a8c\u5242\u91cf","description":"Human Research Ethics Committee\uff08HREC\uff09\u5df2\u6279\u51c6Neurotech International\uff08ASX: NTI\uff09\u5c06\u4e3b\u5bfc\u836f\u7269NTI164\u7528\u4e8e\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\uff08ASD\uff09\u60a3\u8005\u7684\u5242\u91cf\u5ef6\u957f\u4e24\u5e74\uff0c\u8fd9\u4e9b\u60a3\u8005\u4e4b\u524d\u53c2\u52a0\u4e86\u8be5\u516c\u53f8\u7684I\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Neurotech\u83b7\u51c6\u5ef6\u957fNTI164\u5bf9\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\u60a3\u8005\u7684\u8bd5\u9a8c\u5242\u91cf","og_description":"Human Research Ethics Committee\uff08HREC\uff09\u5df2\u6279\u51c6Neurotech International\uff08ASX: NTI\uff09\u5c06\u4e3b\u5bfc\u836f\u7269NTI164\u7528\u4e8e\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\uff08ASD\uff09\u60a3\u8005\u7684\u5242\u91cf\u5ef6\u957f\u4e24\u5e74\uff0c\u8fd9\u4e9b\u60a3\u8005\u4e4b\u524d\u53c2\u52a0\u4e86\u8be5\u516c\u53f8\u7684I\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/","og_site_name":"smallcapsCN","article_published_time":"2023-05-31T01:12:03+00:00","article_modified_time":"2023-08-29T17:58:05+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Neurotech-International-ASX-NTI-dosage-extension-NTI164-patients-in-autism-spectrum-disorder-trial-compassionate-use.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/","url":"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/","name":"Neurotech\u83b7\u51c6\u5ef6\u957fNTI164\u5bf9\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\u60a3\u8005\u7684\u8bd5\u9a8c\u5242\u91cf","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-05-31T01:12:03+00:00","dateModified":"2023-08-29T17:58:05+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"Human Research Ethics Committee\uff08HREC\uff09\u5df2\u6279\u51c6Neurotech International\uff08ASX: NTI\uff09\u5c06\u4e3b\u5bfc\u836f\u7269NTI164\u7528\u4e8e\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\uff08ASD\uff09\u60a3\u8005\u7684\u5242\u91cf\u5ef6\u957f\u4e24\u5e74\uff0c\u8fd9\u4e9b\u60a3\u8005\u4e4b\u524d\u53c2\u52a0\u4e86\u8be5\u516c\u53f8\u7684I\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/neurotech-dosage-extension-nti164-patients-autism-spectrum-disorder-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Neurotech\u83b7\u51c6\u5ef6\u957fNTI164\u5bf9\u81ea\u95ed\u75c7\u8c31\u7cfb\u969c\u788d\u60a3\u8005\u7684\u8bd5\u9a8c\u5242\u91cf"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6891"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6891"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6891\/revisions"}],"predecessor-version":[{"id":20689,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6891\/revisions\/20689"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/19167"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}